Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Multicenter randomized double-blind placebo-controlled phase II trial of injectable brozopine sodium in acute ischemic stroke
CTR20192145Phase 2Completed
- Sponsor
- Zhengzhou University
- Start
- Nov 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of brozopine sodium in ischemic stroke, sponsored by Zhengzhou University. Started Nov 2019; status: completed.
02
Drugs
brozopine sodium
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on CTR20192145.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20192145.